Molecular Testing in Thyroid Cancer
0 意见
• 07/01/23
0
0
嵌入
Panelists R. Michael Tuttle, MD; Eric J. Sherman, MD; Marcia S. Brose, MD, PhD; Naifa Busaidy, MD, FAPC, FACE; and Frank Worden, MD, discuss the present day use of molecular testing for thyroid cancer, which, for now, is largely prognostic but not predictive.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论